Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • rnaNGS
    Member
    • Dec 2009
    • 44

    #1

    decoding tumor expression patterns of lncRNAs, miRNAs, ceRNAs from 14 cancer types

    starBase panCancerMine platform were developed to explore Pan-Cancer patterns of lncRNAs, miRNAs, ceRNAs, RNA-binding proteins (RBPs) and mRNAs from The Cancer Genome Atlas (TCGA) 14 cancer types(>6000 samples. RNA-Seq, miRNA-Seq data)

    starBase Pan-Cancer Analysis is freely available at http://starbase.sysu.edu.cn/panCancer.php.

    this platform provides interactive BarPlot, ScatterPlot and BoxPlot charts and diverse statistics test to explore Pan-Cancer patterns of lncRNAs, miRNAs, ceRNAs and RBPs.

    starBase provides the following Pan-Cancer Analysis Services:
    1. starBase constructed Pan-Cancer expression profiles of lncRNAs, miRNAs and mRNAs from TCGA RNA-Seq and miRNA-Seq data(tumor vs. normal).

    2. starBase generated Pan-Cancer networks of CLIP-Seq experimentally supported miRNA-lncRNA and miRNA-mRNA interactions.

    3. starBase identified Pan-Cancer ceRNA networks involving lncRNAs and mRNAs by analyzing >6000 tumor and normal samples and CLIP-Seq suppored miRNA-target interactions.

    4. starBase firstly provided Pan-Cancer maps of interactions between RNA-binding proteins (RBPs) and RNAs (lncRNAs, mRNAs).

    5. starBase developed Pan-Cancer ceRNAFunction and miRFunction softwares to predict functions of lncRNAs and mRNAs from Pan-Cancer ceRNA and miRNA networks.
    Last edited by rnaNGS; 02-11-2014, 09:59 PM.
  • rnaNGS
    Member
    • Dec 2009
    • 44

    #2
    Overview: starBase Pan-Cancer Analysis of lncRNAs, miRNAs, ceRNAs, RBPs

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
      by SEQadmin2



      Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

      Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
      ...
      10-14-2026, 09:55 AM
    • SEQadmin2
      New Genomics Technologies Take Aim at Long-Standing Limits
      by SEQadmin2


      Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

      We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
      ...
      09-28-2026, 10:25 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, 10-22-2026, 11:13 AM
    0 responses
    53 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-22-2026, 10:48 AM
    0 responses
    39 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-15-2026, 10:52 AM
    0 responses
    46 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-14-2026, 05:39 AM
    0 responses
    46 views
    0 reactions
    Last Post SEQadmin2  
    Working...